Figure 3: A. Effect of liposomal β-Glucan formulations on cell viability. A549 cell viability after 24 hours treatment with various concentrations of liposomal β-Glucan in absence. B. In the presence of 1μM Doxorubicin. Results are expressed as a percentage of PBS-treated cells. Concentrations are relative to the amount of encapsulated component in the liposomal β-Glucan formulation. NOTE: The empty liposomal formulations did not show any toxicity and all cells remain viable. ****P<0.0001.